Synapse Technologies Overview
Latest Deal Amount
$15.3M
Synapse Technologies General Information
Description
Developer of proprietary technology to deliver therapeutic enzymes and other drugs. The company focuses on discovery, development and commercialization of transport systems for therapeutic drug delivery across the blood brain barrier and new drug targets in neurodegenerative disease.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Synapse Technologies Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 2. Merger/Acquisition |
21-Mar-2002 |
$15.3M |
000 |
000.00 |
Completed |
Clinical Trials - General |
| 1. Later Stage VC |
12-Jan-2000 |
000 |
000 |
|
Completed |
Startup |
Synapse Technologies Executive Team (1)
| Name |
Title |
Board Seat |
Contact Info |
| Z Ruttonsha |
Chief Executive Officer & President |
|
|